Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Haemonetics Corp (HAE)

Haemonetics Corp (HAE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,763,524
  • Shares Outstanding, K 46,810
  • Annual Sales, $ 1,361 M
  • Annual Income, $ 167,680 K
  • EBIT $ 277 M
  • EBITDA $ 407 M
  • 60-Month Beta 0.29
  • Price/Sales 2.87
  • Price/Cash Flow 11.59
  • Price/Book 4.74

Options Overview Details

View History
  • Implied Volatility 29.96% (-3.07%)
  • Historical Volatility 82.15%
  • IV Percentile 3%
  • IV Rank 5.89%
  • IV High 72.27% on 10/21/25
  • IV Low 27.31% on 12/08/25
  • Expected Move (DTE 3) 6.64 (8.20%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 16
  • Volume Avg (30-Day) 191
  • Put/Call OI Ratio 0.30
  • Today's Open Interest 8,045
  • Open Int (30-Day) 7,495
  • Expected Range 74.32 to 87.60

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 1.27
  • Number of Estimates 5
  • High Estimate 1.28
  • Low Estimate 1.26
  • Prior Year 1.19
  • Growth Rate Est. (year over year) +6.72%

Price Performance

See More
Period Period Low Period High Performance
1-Month
73.04 +10.56%
on 11/17/25
87.32 -7.52%
on 12/10/25
+7.26 (+9.89%)
since 11/14/25
3-Month
47.31 +70.68%
on 09/26/25
87.32 -7.52%
on 12/10/25
+29.73 (+58.28%)
since 09/16/25
52-Week
47.31 +70.68%
on 09/26/25
87.32 -7.52%
on 12/10/25
-1.50 (-1.82%)
since 12/16/24

Most Recent Stories

More News
Why Haemonetics (HAE) Shares Are Trading Lower Today

Why Haemonetics (HAE) Shares Are Trading Lower Today

HAE : 80.61 (+0.26%)
Why Haemonetics (HAE) Stock Is Down Today

Why Haemonetics (HAE) Stock Is Down Today

HAE : 80.61 (+0.26%)
3 Unpopular Stocks We Steer Clear Of

3 Unpopular Stocks We Steer Clear Of

HAE : 80.61 (+0.26%)
DENN : 6.20 (unch)
HG : 27.65 (-2.47%)
Teleflex, Solventum, Haemonetics, Centene, and Molina Healthcare Shares Skyrocket, What You Need To Know

Teleflex, Solventum, Haemonetics, Centene, and Molina Healthcare Shares Skyrocket, What You Need To Know

SOLV : 81.02 (-1.06%)
TFX : 125.00 (-1.36%)
MOH : 160.57 (-3.56%)
CNC : 38.74 (-4.23%)
HAE : 80.61 (+0.26%)
3 Reasons to Sell HAE and 1 Stock to Buy Instead

3 Reasons to Sell HAE and 1 Stock to Buy Instead

HAE : 80.61 (+0.26%)
1 Mooning Stock with Impressive Fundamentals and 2 We Ignore

1 Mooning Stock with Impressive Fundamentals and 2 We Ignore

TDC : 30.04 (-0.36%)
FROG : 65.43 (-1.09%)
HAE : 80.61 (+0.26%)
5 Insightful Analyst Questions From Haemonetics’s Q3 Earnings Call

5 Insightful Analyst Questions From Haemonetics’s Q3 Earnings Call

HAE : 80.61 (+0.26%)
HAE Q3 Deep Dive: Margin Expansion and Portfolio Rationalization Drive Outperformance

HAE Q3 Deep Dive: Margin Expansion and Portfolio Rationalization Drive Outperformance

HAE : 80.61 (+0.26%)
Why Are Haemonetics (HAE) Shares Soaring Today

Why Are Haemonetics (HAE) Shares Soaring Today

HAE : 80.61 (+0.26%)
Haemonetics (NYSE:HAE) Delivers Impressive Q3, Stock Jumps 12.8%

Haemonetics (NYSE:HAE) Delivers Impressive Q3, Stock Jumps 12.8%

HAE : 80.61 (+0.26%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood...

See More

Key Turning Points

3rd Resistance Point 85.89
2nd Resistance Point 84.11
1st Resistance Point 82.25
Last Price 80.61
1st Support Level 78.61
2nd Support Level 76.83
3rd Support Level 74.97

See More

52-Week High 87.32
Last Price 80.61
Fibonacci 61.8% 72.04
Fibonacci 50% 67.32
Fibonacci 38.2% 62.60
52-Week Low 47.31

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar